A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.

scientific article published on 17 August 2006

A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VIROL.2006.07.020
P698PubMed publication ID16919704
P5875ResearchGate publication ID6867891

P2093author name stringGautam K Sahu
Jiaxiang Ji
Kyeongeun Lee
Miles W Cloyd
Samuel Baron
Vivian Braciale
P2860cites workThe phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1Q24293229
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected childrenQ24620746
The challenge of viral reservoirs in HIV-1 infectionQ28216956
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infectionQ28237240
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapyQ28253761
Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infectionQ28646867
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapyQ29615992
Recovery of replication-competent HIV despite prolonged suppression of plasma viremiaQ29615995
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.Q29619254
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionQ29619738
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapyQ33932746
Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell lineQ34070377
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuliQ34124009
Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytesQ34162002
Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposureQ34345655
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.Q34985945
Cytokines and T cell homeostasisQ35044781
Activation-induced cell death in T cellsQ35129715
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivoQ35149006
Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytesQ36368207
Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.Q36369965
Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latencyQ36632804
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loadsQ36943833
A point mutation in the HIV-1 Tat responsive element is associated with postintegration latencyQ37518835
Production of HIV-1 by resting memory T lymphocytesQ39027523
Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapyQ39685944
Effects of prostratin on T-cell activation and human immunodeficiency virus latencyQ39753161
Rapid expression of human immunodeficiency virus following activation of latently infected cellsQ40329064
Differential activation of Tat variants in mitogen-stimulated cells: implications for HIV-1 postintegration latencyQ40642204
IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cellsQ40778669
Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV).Q41141994
Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequencesQ41154551
Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latencyQ41730261
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneQ41764642
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigenQ41830365
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 yearsQ43569408
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).Q44072577
HIV infection of primary human T cells is determined by tunable thresholds of T cell activationQ44910147
Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agentsQ44928571
HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infectionQ45345418
Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapyQ45735020
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissuesQ46126584
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapyQ47960975
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.Q51993308
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.Q52007779
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.Q52030166
In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.Q52050894
Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyQ57075703
Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T CellsQ57075707
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1Q72688559
CD4+ T cell survival is not directly linked to self-MHC-induced TCR signalingQ73035416
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapyQ73162446
Nonproliferating bystander CD4+ T cells lacking activation markers support HIV replication during immune activationQ73850608
Productive HIV Infection of Resting CD4+T Cells: Role of Lymphoid Tissue Microenvironment and Effect of Immunomodulating AgentsQ79222510
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)127-137
P577publication date2006-08-17
P1433published inVirologyQ7934867
P1476titleA novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.
P478volume355